In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Molecular diagnostics company CareDx nets $8.4mm in FOPO

Executive Summary

CareDx Inc. (molecular diagnostics for transplant patients) netted $8.4mm in a follow-on public offering of 2.25mm common shares at $4. Earlier in the year the company raised additional funds in a private placement to support its acquisition of Allenex AB. The company will use the proceeds to support the continued development of AlloSure for a clinical utility trial and commercialization.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies